A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea

Suffolk OBGYN, Port Jefferson

Tidewater Clinical Research, Virginia Beach

Lyndhurst Clinical Research, Winston-Salem

Wake Research Associates, Raleigh

Vista Clinical Research, Columbia

Comprehensive Clinical Trials, LLC, West Palm Beach

Nature Coast Clinical Research, Crystal River

Chattanooga Medical Research, Chattanooga

University of Cincinnati Physicians Company, Cincinnati

HWC Women's Research Center, Englewood

Cypress Medical Research Center, Wichita

Women's Clinic of Lincoln, P.C., Lincoln

Methodist Charlton Medical Center, DeSoto

The Woman's Hospital of Texas Clinical Research Center, Houston

PRO/Salt Lake Women's Center, Sandy City

Precision Clinical Trials/Arizona Wellness Center for Women, Phoenix

Precision Trials/New Horizons Women's Care, Chandler

Visions Clinical Research, Tucson

California Family Health Council, Los Angeles

California Family Health Council, Berkeley

Clinical Research Consulting, Milford

Lawrence OB-Gyn Clinical Research, Lawrenceville